Joseph C Paviglianiti is categorized under Internal Medicine Doctors in Cranberry Twp, PA and active since 2008.
Joseph C Paviglianiti was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Joseph Paviglianiti at the company’s single location by writing to 20397 Route 19 # 724, Cranberry Twp, Pennsylvania PA 16066 or by phoning (724) 772-3388. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Joseph C Paviglianiti |
| Contact Person: | Joseph Paviglianiti |
| Address: | 20397 Route 19 # 724, Cranberry Twp, Pennsylvania 16066 |
| Phone Number: | (724) 772-3388 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Joseph C Paviglianiti was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph Paviglianiti for inquiries that concern Joseph C Paviglianiti by calling the company number (724) 772-3388, as your correspondence is most welcome. Additionally, the physical location of the single location of Joseph C Paviglianiti can be found at the coordinates 40.693951,-80.104455 as well as the street address 20397 Route 19 # 724 in Cranberry Twp, Pennsylvania 16066.
For its online presence, you may visit Joseph C Paviglianiti’s website at and engage with its social media outlets through on Twitter and on Facebook.